Clayton has been with Freeman Technology since 2008 in a role that has encompassed both sales and applications support. As operations manager he will be responsible for all the day-to-day activities of the company, including overall management of the administration, production, r&d, sales and customer support teams.
In expanding the management team Tim Freeman, director of operations, anticipates further growth and greater opportunity to contribute expertise to the powder processing industries.
‘We want to deliver the best possible technical and applications support to our customers at all times and part of Jamie’s new role will be to ensure that every aspect of our operation runs efficiently,’ he said.
Freeman Technology appoints operations manager
Jamie Clayton takes responsibility for day-to-day activities
You may also like
Manufacturing
RION engages Lonza to scale manufacturing exosome based therapeutics
Collaboration leverages RION’s proprietary biomanufacturing process to propel RION’s industry-leading clinical development pipeline towards late-phase trials and commercialisation for multiple regenerative medical conditions
Manufacturing
Quantoom Biosciences partners with Memorial Sloan Kettering Cancer Center to advance personalised mRNA cancer therapeutics
Quantoom Biosciences will use MSK's proprietary lipid nanoparticle technology, Ncapsulate QCX-002, in the development of personalised RNA-based cancer therapies, with plans to support upcoming Phase I clinical trials
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Analysis
The long and short of it: a new way to analyse ultrashort-, short- and long-chain PFAS simultaneously (part I)
SCIEX PFAS expert, Craig Butt (pictured), explores innovative methods that enable the rapid, sensitive detection and monitoring of ultrashort-, short- and long-chain PFAS in complex environmental matrices such as air and seawater